IBDEI180 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21837,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,21838,0)
 ;;=V10.43^^133^1320^43
 ;;^UTILITY(U,$J,358.3,21838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21838,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,21838,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,21838,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,21839,0)
 ;;=V12.71^^133^1320^45
 ;;^UTILITY(U,$J,358.3,21839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21839,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,21839,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,21839,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,21840,0)
 ;;=V10.46^^133^1320^48
 ;;^UTILITY(U,$J,358.3,21840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21840,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,21840,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,21840,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,21841,0)
 ;;=V11.0^^133^1320^50
 ;;^UTILITY(U,$J,358.3,21841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21841,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,21841,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,21841,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,21842,0)
 ;;=V10.83^^133^1320^51
 ;;^UTILITY(U,$J,358.3,21842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21842,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,21842,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,21842,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,21843,0)
 ;;=V15.1^^133^1320^53
 ;;^UTILITY(U,$J,358.3,21843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21843,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,21843,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,21843,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,21844,0)
 ;;=V15.82^^133^1320^57
 ;;^UTILITY(U,$J,358.3,21844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21844,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,21844,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,21844,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,21845,0)
 ;;=V12.01^^133^1320^54
 ;;^UTILITY(U,$J,358.3,21845,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21845,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,21845,1,5,0)
 ;;=5^Hx Of TB
 ;;^UTILITY(U,$J,358.3,21845,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,21846,0)
 ;;=V13.01^^133^1320^34
 ;;^UTILITY(U,$J,358.3,21846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21846,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,21846,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,21846,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,21847,0)
 ;;=V12.51^^133^1320^59
 ;;^UTILITY(U,$J,358.3,21847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21847,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,21847,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,21847,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,21848,0)
 ;;=V17.89^^133^1320^17
 ;;^UTILITY(U,$J,358.3,21848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21848,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,21848,1,5,0)
 ;;=5^Family H/O Musculosk Dis
 ;;^UTILITY(U,$J,358.3,21848,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,21849,0)
 ;;=V12.54^^133^1320^56
 ;;^UTILITY(U,$J,358.3,21849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21849,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,21849,1,5,0)
 ;;=5^Hx Of TIA
 ;;^UTILITY(U,$J,358.3,21849,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,21850,0)
 ;;=V12.54^^133^1320^52
 ;;^UTILITY(U,$J,358.3,21850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21850,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,21850,1,5,0)
 ;;=5^Hx Of Stroke w/o Residuals
